Assembly Biosciences, Inc.
ASMB
$26.93
$0.281.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.63M | 9.42M | 7.36M | 6.85M | 8.53M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.63M | 9.42M | 7.36M | 6.85M | 8.53M |
| Cost of Revenue | 16.13M | 14.85M | 14.28M | 13.52M | 16.26M |
| Gross Profit | -6.50M | -5.43M | -6.92M | -6.67M | -7.73M |
| SG&A Expenses | 4.59M | 4.51M | 4.61M | 4.29M | 4.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.72M | 19.36M | 18.89M | 17.80M | 20.74M |
| Operating Income | -11.09M | -9.94M | -11.53M | -10.96M | -12.20M |
| Income Before Tax | -10.20M | -8.82M | -10.41M | -9.61M | -10.75M |
| Income Tax Expenses | -- | -- | -76.00K | -- | 406.00K |
| Earnings from Continuing Operations | -10.20M | -8.82M | -10.34M | -9.61M | -11.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.20M | -8.82M | -10.34M | -9.61M | -11.15M |
| EBIT | -11.09M | -9.94M | -11.53M | -10.96M | -12.20M |
| EBITDA | -11.06M | -9.91M | -11.50M | -10.92M | -12.17M |
| EPS Basic | -1.33 | -1.17 | -1.58 | -1.51 | -1.98 |
| Normalized Basic EPS | -0.83 | -0.73 | -1.00 | -0.95 | -1.19 |
| EPS Diluted | -1.33 | -1.17 | -1.58 | -1.51 | -1.98 |
| Normalized Diluted EPS | -0.83 | -0.73 | -1.00 | -0.95 | -1.19 |
| Average Basic Shares Outstanding | 7.66M | 7.51M | 6.54M | 6.35M | 5.64M |
| Average Diluted Shares Outstanding | 7.66M | 7.51M | 6.54M | 6.35M | 5.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |